共 130 条
[1]
Lumry WR(2013)Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema Am J Manag Care 19 s103-s110
[2]
Zuraw BL(2008)Clinical practice. Hereditary angioedema N Engl J Med 359 1027-1036
[3]
Bygum A(2009)Hereditary angio-oedema in Denmark: a nationwide survey Br J Dermatol 161 1153-1158
[4]
Agboola F(2019)The Effectiveness and value of lanadelumab and C1 esterase inhibitors for prophylaxis of hereditary angioedema attacks: a summary from the institute for clinical and economic review’s california technology assessment forum J Manag Care Spec Pharm 25 143-148
[5]
Lubinga S(2013)Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys Allergy Asthma Proc 34 261-266
[6]
Carlson J(2013)US hereditary angioedema association medical advisory board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency J Allergy Clin Immunol Pract 1 458-467
[7]
Lin GA(2018)Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States Orphanet J Rare Dis 13 1-7
[8]
Dreitlein WB(2021)US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema J Allergy Clin Immunol Pract 9 132-150
[9]
Pearson SD(2021)Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report Allergy Asthma Clin Immunol 17 1-14
[10]
Reshef A(2021)Patient-reported outcome measures for angioedema: a literature review Acta Derm Venereol 101 adv00456-710